54. Adult still disease Clinical trials / Disease details

Clinical trials : 2 / Drug : 1 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 12

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000001457	2008/10/01	28/10/2008	The efficacy evaluation of tocilizumabto glucocorticoid-resistant patients with adult Still's diseas ...		Adult Still's disease and systemic juvenile idiopathic arthritis	Tocilizumab is to be infused every 2 to 4 weeks at 8 mg/kg of body weight	Division of Rheumatology & Clinical Immunology, Jichi Medical University	NULL	Complete: follow-up complete	16years-old	Not applicable	Male and Female	10	Not selected	Japan
2	JPRN-UMIN000001250	2008/07/01	16/07/2008	Study on the glucocorticoid-sparing effects of tocilizumabamong glucocorticoid-dependent patients wi ...		Adult Still's disease or systemic juvenile idiopathic arthritis	Tocilizumab (8 mg/kg of body weight) is to be infused every 2 to 4 weeks.	Division of Rheumatology & Clinical Immunology, Jichi Medical University	NULL	Complete: follow-up complete	16years-old	Not applicable	Male and Female	10	Not selected	Japan

First Previous1Next Last